Fonseca, Pandora Eloa Oliveira, Jeremias Aguiar Azevedo, Sara Maria Gomes Bié, and Sávio Benvindo Ferreira. “Benefits of Using SLGT2 Inhibitors for Patients With CDK and DM2 to Reduce Mortality Risks”. Archives of Pharmacy and Pharmaceutical Sciences 8, no. 1 (May 2, 2024): 041–046. Accessed October 4, 2025. https://www.pharmacyscijournal.com/apps/article/view/apps-aid1055.